HCP-level multichannel exposure-to-prescription attribution panel

HCP-level multichannel exposure-to-prescription attribution panel: per-NPI records of which advertisement, e-detailing piece, peer signal or field interaction an individual prescriber received and which downstream prescription, quality website visit or field activation it is credited with, spanning digital, personal and peer channels. Layered on top: patient-eligibility trigger signals (patient started or stopped therapy, content deployed within 24 hours), Next-Best-Action and affinity model outputs, and publisher-level engagement performance across 75,000+ publishers and 75+ specialist partners.

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks PharmaForceIQ and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: PharmaceuticalsMarketing
Instruments: equities
Categories: Alternative

Dataset card

Type: not stated
Format: Tabular event and impression logs joined to prescription outcomes (NPI-keyed), plus creative-content metadata recording which asset, format and channel was served, delivered as a streaming/live feed structure — the platform emphasizes live dashboards and continuous data refresh over quarterly reporting.
Volume: Very large exposure stream. Vendor-stated inventory: 75,000+ publishers, 75+ endemic specialist partners, and ~80% real-world data coverage implying reach across most of the US prescriber universe. Estimated ~10^8-10^9 exposure events monthly with NPI-level attribution retained against eligibility signals. The monthly rate is an inference from always-on campaign operation, not a vendor figure.
Users: N/A as a registered-user concept — a login-gated hosted platform sold to pharma commercial teams, so the meaningful population is an estimated 1,000-5,000 client seats across pharma and agency accounts (inferred from ~210 employees serving enterprise life-sciences customers). The data subjects, not the users, are the asset: stated ~80% real-world data coverage implies linkage across most of the ~1M US prescriber universe.
History: 6 years
Update frequency: not stated
Growth: Active and expanding — launched Optichannel 360, billed as an AI-native answer-to-action engine for pharma commercial teams, with the launch badge and current site branding both dated to 2025, and the corporate record shows a subsequent combination or ownership event. A live application portal, multiple named solution lines segmented by buyer role, and continuous data-refresh positioning all indicate a growing operating business rather than a run-off product.
Launched: Platform era ~2019-2021 — the corporate profile's founding-era identifier dates to 2021 and the company has since passed through an ownership event. The AI-native Optichannel 360 decisioning layer is materially newer, launched 2025 per the site's own announcement. Read it as a two-stage timeline: advertising-technology platform first, AI decisioning layer added in 2025.
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site